
Hangzhou Jirui Technology Co., Ltd.
Hangzhou Jirui Technology Co., Ltd. was established in September 2018. It is an innovative biomedical enterprise specializing in the automatic synthesis platform of nuclear medicine molecular imaging tracer drugs, research and development, production and sales of radiopharmaceuticals. The company has set up a research and development team composed of high-level talents at home and abroad, such as Zhejiang University and UCLA. Relying on the R & D resources of the Key Laboratory of Medical Molecular Imaging of Zhejiang Province and the Key Laboratory of Biomedical Engineering of the Ministry of Education of Zhejiang University, based on the nuclear medicine industry, focusing on independent research and development, and cooperating with external cooperation models, in tumors, cardiovascular and cerebrovascular diseases, Neurodegenerative diseases and other fields have gradually created a full-chain development pattern integrating nuclear medicine molecular imaging tracer synthesis devices and nuclear medicine (diagnostic and therapeutic) R & D, production and sales.

As a fast-growing technology enterprise, the company's brand value is gradually formed in the field of nuclear medicine imaging. We will continue to uphold the core values of innovation, professionalism and responsibility, and continue to strive for excellence and contribute to the cause of human health. We welcome people with lofty ideals to join us and work together to build a better future.